Yuman seems to be very keen to 'take on' any/all cancer types. This shows enormous confidence. As I have mentioned before, the majority of cancer trials, up to this time, have carefully targeted very specific cancers in an effort to maximise success. We understand this ... trials can be hugely expensive, not to mention time consuming, so you want to give yourself the very best chance of a 'win'. Yuman is a doctor, and by nature is careful in every way, so it would appear that he is 'looking at' not only a safe treatment, but one that 'obliterate' many cancer types. A treatment that can do all that, will put IMU well ahead of the rest of the field. I am certainly looking forward to seeing which cancers it does smash.
Hi TB @Taureanbull You are also correct ... the "Vaccinia trial is designed to kick open the doors for every solid tumor that gets a CD8 response from the immune system." Yuman want the virus to more than just seek out tumours, he also wants to turn on the immune system. What CF33 does well is recruit CD8+ cells, and as we know, these guys are T-Cells that kill cancer. He is looking to 'unleash the hounds of hell' (my words) onto those cancer cells, in a safe way (of course). This is very cool science.
As usual, this is not financial advice, just opinion.
IMU Price at posting:
15.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)